purchase customization

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
1.2 Key Market Segments
1.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Type
1.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Overview
2.1 Global Market Overview
2.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Competitive Landscape
3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Manufacturers (2019-2024)
3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Manufacturers (2019-2024)
3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Sites, Area Served, Product Type
3.6 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Competitive Situation and Trends
3.6.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Chain Analysis
4.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2019-2024)
6.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2019-2024)
6.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Price by Type (2019-2024)
7 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Sales by Application (2019-2024)
7.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD) by Application (2019-2024)
7.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Application (2019-2024)
8 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Segmentation by Region
8.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region
8.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region
8.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region
8.2 North America
8.2.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche (Genentech)
9.1.1 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.1.2 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.1.4 Roche (Genentech) Business Overview
9.1.5 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
9.1.6 Roche (Genentech) Recent Developments
9.2 Amgen
9.2.1 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.2.2 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.2.4 Amgen Business Overview
9.2.5 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
9.2.6 Amgen Recent Developments
9.3 B-MS
9.3.1 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.3.2 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.3.4 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
9.3.5 B-MS Business Overview
9.3.6 B-MS Recent Developments
9.4 Merck
9.4.1 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.4.2 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.4.4 Merck Business Overview
9.4.5 Merck Recent Developments
9.5 Pfizer
9.5.1 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.5.2 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Recent Developments
9.6 Novartis
9.6.1 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.6.2 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Eli Lilly and Company
9.7.1 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.7.2 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.7.4 Eli Lilly and Company Business Overview
9.7.5 Eli Lilly and Company Recent Developments
9.8 Johnson and Johnson
9.8.1 Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.8.2 Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.8.3 Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.8.4 Johnson and Johnson Business Overview
9.8.5 Johnson and Johnson Recent Developments
9.9 GSK
9.9.1 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.9.2 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.9.4 GSK Business Overview
9.9.5 GSK Recent Developments
9.10 Sanofi
9.10.1 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.10.2 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.10.4 Sanofi Business Overview
9.10.5 Sanofi Recent Developments
9.11 Boehringer Ingelheim
9.11.1 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.11.2 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.11.4 Boehringer Ingelheim Business Overview
9.11.5 Boehringer Ingelheim Recent Developments
9.12 Zhejiang Jiuzhou Pharmaceutical
9.12.1 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.12.2 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.12.4 Zhejiang Jiuzhou Pharmaceutical Business Overview
9.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
10 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Region
10.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast
10.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country
10.2.3 Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Region
10.2.4 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type (2025-2030)
11.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type (2025-2030)
11.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Application (2025-2030)
11.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) Forecast by Application
11.2.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings